| 000 | 01293 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512203747.0 | ||
| 264 | 0 | _c19801027 | |
| 008 | 198010s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19800801)46:3<452::aid-cncr2820460305>3.0.co;2-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTannock, I F | |
| 245 | 0 | 0 |
_aChemotherapy for adenocystic carcinoma. _h[electronic resource] |
| 260 |
_bCancer _cAug 1980 |
||
| 300 |
_a452-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlkylating Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Adenoid Cystic _xdrug therapy |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVinca Alkaloids _xadministration & dosage |
| 700 | 1 | _aSutherland, D J | |
| 773 | 0 |
_tCancer _gvol. 46 _gno. 3 _gp. 452-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19800801)46:3<452::aid-cncr2820460305>3.0.co;2-z _zAvailable from publisher's website |
| 999 |
_c6249415 _d6249415 |
||